The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624)
Open accessAbstract
Amyloid beta-peptide (Abeta) is postulated to play a central role in the pathogenesis of Alzheimer's disease. We recently proposed a pathway of Abeta-induced toxicity that is APP dependent and involves the facilitation of APP complex formation by Abeta. The APP-dependent component requires cleavage of APP at position 664 in the cytoplasmic domain, presumably by caspases or caspase-like proteases, with release of a potentially cytotoxic C31 peptide. In this study we show that Abeta interacted directly and specifically with membrane-bound APP to facilitate APP homo-oligomerization. Using chimeric APP molecules, this interaction was shown to take place between Abeta and its homologous sequence on APP. Consistent with this finding, we demonstrated that Abeta also facilitated the oligomerization of beta-secretase cleaved APP C-terminal fragment (C99). We found that the YENPTY domain in the APP cytoplasmic tail and contained within C31 is critical for this cell death pathway. Deletion or alanine- scanning mutagenesis through this domain significantly attenuated cell death apparently without affecting either APP dimerization or cleavage at position 664. This indicated that sequences within C31 are required after its release from APP. As the YENPTY domain has been shown to interact with a number of cytosolic adaptor molecules, it is possible that the interaction of APP, especially dimeric forms of APP, with these molecules contribute to cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Remarkably, it was shown that extracellular Aβ1-42 was not toxic to APP knockout neurons [107] and that even point mutations in the NPXY motif in the C-terminus of APP block toxicity [169].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006 · cited 1×
“Some biological properties have been attributed to APP, including adhesion, neuronal development, synaptogenesis, neurite outgrowth, neuroprotection, and stimulation of proliferation of neuronal progenitor cells (11).”
BackgroundSynaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
Selkoe, D. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01363-4 · Cited by 862
Gervais, F. G., Xu, D., Robertson, G. S., Vaillancourt, J. P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M. S., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80748-5 · Cited by 674
Pathologic conformations of prion proteins.
Cohen, F., & Prusiner, S. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.793 · Cited by 533
Klein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 494
Sastre, M., Steiner, H., Fuchs, K. P., Capell, A., Multhaup, G., Condron, M. M., Teplow, D. B., & Haass, C. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve180 · Cited by 472
Wasco, W., Gurubhagavatula, S., Paradis, M. D., Romano, D., Sisodia, S. S., Hyman, B. T., Neve, R. L., & Tanzi, R. E. (1993) · Nature Genetics · doi:10.1038/ng0993-95 · Cited by 404
Wasco, W., Bupp, K., Magendantz, M., Gusella, J. F., Tanzi, R. E., & Solomon, F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10758 · Cited by 399
A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor
Lu, D. C.-T., Rabizadeh, S., Chandra, S. S., Shayya, R. F., Ellerby, L., Ye, X., Salvesen, G. S., Koo, E. H., & Bredesen, D. E. (2000) · Nature Medicine · doi:10.1038/74656 · Cited by 395
Self-citationSlunt, H. H., Thinakaran, G., von Koch, C., Lo, A., Tanzi, R. E., & Sisodia, S. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41992-2 · Cited by 346
Kim, T., Pettingell, W. H., Jung, Y., Kovacs, D. M., & Tanzi, R. E. (1997) · Science · doi:10.1126/science.277.5324.373 · Cited by 340
Sisodia, S., Koo, E., Hoffman, P., Perry, G. L., & Price, D. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-07-03136.1993 · Cited by 284
Self-citationLorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
Scheuermann, S., Hambsch, B., Hesse, L., Stumm, J., Schmidt, C., Beher, D., Bayer, T. A., Beyreuther, K. T., & Multhaup, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105410200 · Cited by 216
Eggert, S., Paliga, K., Soba, P., Evin, G. M., Masters, C. L., Weidemann, A., & Beyreuther, K. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311601200 · Cited by 212
Levites, Y. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25410 · Cited by 209
Sprecher, C. A., Grant, F. J., Grimm, G., O’Hara, P. J., Norris, F., Norris, K. E., & Foster, D. C. (1993) · Biochemistry · doi:10.1021/bi00068a002 · Cited by 191
Guichet, A., Copeland, J. W. R., Erdélyi, M., Hlousek, D., Závorszky, P., Ho, J., Brown, S. J., Percival‐Smith, A., Krause, H. M., & Ephrussi, A. (1997) · Nature · doi:10.1038/385548a0 · Cited by 189
Kim, H.-S., Kim, E.-M., Lee, J.-P., Park, C. H., Kim, S., Seo, J.-H., Chang, K.-A., Yu, E., Jeong, S.-J., Chong, Y. H., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0106fje · Cited by 183
Weidemann, A., Paliga, K., Dürrwang, U., Reinhard, F. B. M., Schuckert, O., Evin, G. M., & Masters, C. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.9.5823 · Cited by 179
The X-Ray Structure of an Antiparallel Dimer of the Human Amyloid Precursor Protein E2 Domain
Wang, Y., & Ha, Y. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.06.037 · Cited by 147
Processing of β-Amyloid Precursor-like Protein-1 and -2 by γ-Secretase Regulates Transcription
Scheinfeld, M. H., Ghersi, E., Laky, K., Fowlkes, B. J., & D'adamio, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208110200 · Cited by 141
Pellegrini, L., Passer, B. J., Tabaton, M., Ganjei, J. K., & D'Adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21011 · Cited by 139
Marquez-Sterling, N. R., Lo, A., Sisodia, S. S., & Koo, E. H. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-01-00140.1997 · Cited by 124
Self-citationCaspase cleavage of the amyloid precursor protein modulates amyloid β‐protein toxicity
Lu, D. C.-T., Soriano, S., Bredesen, D. E., & Koo, E. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02059.x · Cited by 119
Self-citationKinoshita, A., Whelan, C. M., Berezovska, O., & Hyman, B. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203372200 · Cited by 109
Zhao, M., Su, J. H., Head, E., & Cotman, C. W. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.006 · Cited by 97
Caspase cleavage of members of the amyloid precursor family of proteins
Galván, V., Chen, S., Lu, D. C.-T., Logvinova, A. V., Goldsmith, P., Koo, E. H., & Bredesen, D. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00970.x · Cited by 96
Self-citationAmyloid β protein toxicity mediated by the formation of amyloid‐β protein precursor complexes
Lu, D. C.-T., Shaked, G. M., Masliah, E., Bredesen, D. E., & Koo, E. H. (2003) · Annals of Neurology · doi:10.1002/ana.10761 · Cited by 92
Self-citationADDLs & protofibrils —the missing links?
Klein, W. L. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00312-8 · Cited by 77
Su, J. H., Kesslak, P. J., Head, E., & Cotman, C. W. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0548-2 · Cited by 76
Soriano, S., Lu, D. C.-T., Chandra, S. S., Pietrzik, C. U., & Koo, E. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102456200 · Cited by 73
Self-citationHuman Amyloid Precursor‐Like Protein 1
Paliga, K., Peraus, G., Kreger, S., Dürrwang, U., Hesse, L., Multhaup, G., Masters, C. L., Beyreuther, K. T., & Weidemann, A. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0354a.x · Cited by 64
FTZ‐Factor1 and Fushi tarazu interact via conserved nuclear receptor and coactivator motifs
Schwartz, C. J. E., Sampson, H. M., Hlousek, D., Percival‐Smith, A., Copeland, J. W. R., Simmonds, A. J., & Krause, H. M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.510 · Cited by 61
Maltese, W. A., Wilson, S. E., Tan, Y., Suomensaari, S., Sinha, S., Barbour, R., & McConlogue, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007238200 · Cited by 60
Melchor, J. P., & Nostrand, W. E. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9782 · Cited by 48
Localization of a Fibrillar Amyloid β-Protein Binding Domain on Its Precursor
Nostrand, W. E. V., Melchor, J. P., Keane, D. M., Saporito-Irwin, S. M., Romanov, G. A., Davis, J., & Xu, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204676200 · Cited by 47
Dumanchin‐Njock, C., da Costa, C. A., Mercken, L., Pradier, L., & Checler, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00513.x · Cited by 40
Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid β precursor protein
Heredia, L., Lin, R., Vigo, F. S., Kedikian, G., Busciglio, J. A., & Lorenzo, A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.015 · Cited by 27
Cited by
Sorted by citations
Yankner, B. A., Lu, T., & Loerch, P. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.092044 · Cited by 677
Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease
Gouras, G. K., Tampellini, D., Takahashi, R. H., & Capetillo-Zarate, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0679-9 · Cited by 372
β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease
Gouras, G. K., Olsson, T. T., & Hansson, O. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0313-y · Cited by 346
Synaptic changes in Alzheimer’s disease and its models
Pozueta, J., Lefort, R., & Shelanski, M. L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.050 · Cited by 319
Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade
Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179935 · Cited by 313
Metadata
- Authors
- Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V., Bredesen, D. E., Koo, E. H., Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V., Bredesen, D. E., & Koo, E. H.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2006-04-24
- Volume
- 20
- Issue
- 8
- Pages
- 1254-1256
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC1847355
- OpenAlex
- W2108938583
- Cited by
- 132
- References
- 44
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 7 · 2023: 4 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 12 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 9 · 2012: 6
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (AG05131)
- Alzheimer's Association
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, Alzheimer's disease, APP, APP C-terminal fragments, caspase-like proteases, cell death
- MeSH terms
- Amino Acid Sequence, Animals, Membrane Proteins, Molecular Sequence Data, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Cell Death, Protein Structure, Tertiary, Amino Acid Motifs, Cell Line, Tumor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review